SCHEMBL21633429

SCHEMBL21633429

CC(Oc1ccc(C(=O)c2c(-c3ccc(O)cc3)sc3cc(O)ccc23)cc1)C1CCNCC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 19/20 0.57
ESR2 Q92731 11/20 0.57
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
TDP1 Q9NUW8 3/20 0.54
ALDH1A1 P00352 2/20 0.52
LMNA P02545 2/20 0.52
TP53 P04637 2/20 0.52
CYP3A4 P08684 2/20 0.52
MAPT P10636 2/20 0.52
ALOX15 P16050 2/20 0.52
HSD17B10 Q99714 2/20 0.52
PLD2 O14939 1/20 0.52
KDM1A O60341 1/20 0.52
NR1I2 O75469 1/20 0.52
USP2 O75604 1/20 0.52
C5 P01031 1/20 0.52
FYN P06241 1/20 0.52
PGR P06401 1/20 0.52
ADRA2A P08913 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6836408 0.90 ESR1 (0.55) ESR1ESR2MEN1KMT2ATDP1
SCHEMBL8310884 0.87 ESR1 (0.52) ESR1ESR2MEN1KMT2ATDP1
SCHEMBL14559000 0.86 ESR1 (0.70) ESR1ESR2MEN1KMT2ATDP1
SCHEMBL6765919 0.85 ESR1 (0.56) ESR1ESR2MEN1KMT2ATDP1
Hydrochloric Acid SCHEMBL6767212 0.84 ESR1 (0.55) ESR1ESR2MEN1KMT2ATDP1
SCHEMBL7967875 0.83 ESR1 (0.49) ESR1ESR2MEN1KMT2ATDP1
1,2-Dichloroethane SCHEMBL6766357 0.81 ESR1 (0.53) ESR1ESR2MEN1KMT2ATDP1
SCHEMBL6835772 0.81 ESR1 (0.53) ESR1ESR2MEN1KMT2ATDP1
SCHEMBL11185523 0.80 ESR1 (0.64) ESR1ESR2MEN1KMT2ATDP1
Chlorobenzene SCHEMBL6765632 0.79 ESR1 (0.49) ESR1ESR2MEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200030259-A1 Antiestrogens and/or Aromatase Inhibitors for Use in Treating Obesity and Related Symptoms REPROS THERAPEUTICS INC (US) 2020-01-30 US disclosed